DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR SAXAGLIPTIN HYDROCHLORIDE
All Clinical Trials for Saxagliptin Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00121641 ↗ | Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise | Completed | AstraZeneca | Phase 3 | 2005-07-01 | The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is more effective than placebo as a treatment for type 2 diabetic subjects who are not sufficiently controlled with diet and exercise |
| NCT00121667 ↗ | Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone | Completed | AstraZeneca | Phase 3 | 2005-08-01 | The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone |
| NCT00295633 ↗ | A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone | Completed | AstraZeneca | Phase 3 | 2006-03-01 | The purpose of this clinical research study is to learn whether Saxagliptin added to thiazolidinedione (TZD) therapy is more effective than TZD alone as a treatment for Type 2 diabetic subjects who are not sufficiently controlled with TZD alone |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Saxagliptin Hydrochloride
Condition Name
Clinical Trial Locations for Saxagliptin Hydrochloride
Trials by Country
Clinical Trial Progress for Saxagliptin Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Saxagliptin Hydrochloride
Sponsor Name
